Metropolitan Life Insurance Company (MetLife)’s Schwab US Dividend Equity ETF SCHD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.08M Buy
160,200
+7,300
+5% +$232K 1.42% 10
2026
Q1
$4.69M Sell
152,900
-8,500
-5% -$258K 1.43% 10
2025
Q4
$4.43M Sell
161,400
-29,100
-15% -$791K 1.34% 10
2025
Q3
$5.2M Sell
190,500
-14,200
-7% -$387K 1.52% 10
2025
Q2
$5.42M Buy
204,700
+27,700
+16% +$723K 1.62% 10
2025
Q1
$4.95M Sell
177,000
-3,000
-2% -$83.6K 2.29% 8
2024
Q4
$4.92M Sell
180,000
-65,400
-27% -$1.86M 1.95% 8
2024
Q3
$6.91M Buy
+245,400
New +$6.69M 2.46% 8

Other funds holding SCHD

Metropolitan Life Insurance Company (MetLife)'s SCHD Position: Q2 2026 in Review

Metropolitan Life Insurance Company (MetLife) increased its Schwab US Dividend Equity ETF (SCHD) stake by 4.8% in Q2 2026, buying an estimated $232K and bringing the position to 160,200 shares worth $5.08M. The position accounts for 1.42% of the portfolio, ranked #10.

Metropolitan Life Insurance Company (MetLife) first reported a position in SCHD in Q3 2024 and has held it in 8 quarters since. The position peaked at $6.91M in Q3 2024. 2,148 funds tracked by Wall St. Rank hold SCHD as of Q2 2026.

  • Metropolitan Life Insurance Company (MetLife) held 160,200 shares of Schwab US Dividend Equity ETF worth $5.08M as of Q2 2026.
  • Metropolitan Life Insurance Company (MetLife) bought 7,300 Schwab US Dividend Equity ETF shares in Q2 2026, an estimated $232K.
  • Schwab US Dividend Equity ETF made up 1.42% of Metropolitan Life Insurance Company (MetLife)'s portfolio in Q2 2026, its #10 holding.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Schwab US Dividend Equity ETF in Q3 2024 and has held it in 8 quarters since.
  • Metropolitan Life Insurance Company (MetLife)'s Schwab US Dividend Equity ETF position peaked at $6.91M in Q3 2024.
  • 2,148 funds tracked by Wall St. Rank held Schwab US Dividend Equity ETF as of Q2 2026.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2026, filed 14 Aug 2026.